Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy.
Bai Z, Zhou Y, Ye Z, Xiong J, Lan H, Wang F.
Front Immunol. 2022 Jan 14;12:808964. doi: 10.3389/fimmu.2021.808964. eCollection 2021.
PMID:35095898
Rivaroxaban vs placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer.
Becattini C, Pace U, Pirozzi F, Donini A, Avruscio G, Rondelli F, Boncompagni M, Chiari D, De Prizio M, Visonà A, De Luca R, Guerra F, Muratore A, Portale G, Milone M, Castagnoli G, Righini M, Martellucci J, Persiani R, Frasson S, Dentali F, Delrio P, Campanini M, Gussoni G, Vedovati MC, Agnelli G.
Blood. 2022 Aug 25;140(8):900-908. doi: 10.1182/blood.2022015796.
PMID:35580191
Increased risk of hemorrhage in metastatic colorectal cancer patients treated with bevacizumab: An updated meta-analysis of 12 randomized controlled trials.
Zhu X, Tian X, Yu C, Hong J, Fang J, Chen H.
Medicine (Baltimore). 2016 Aug;95(34):e4232. doi: 10.1097/MD.0000000000004232.
PMID:27559943
Multiplexed single-cell analysis reveals prognostic and nonprognostic T cell types in human colorectal cancer.
Masuda K, Kornberg A, Miller J, Lin S, Suek N, Botella T, Secener KA, Bacarella AM, Cheng L, Ingham M, Rosario V, Al-Mazrou AM, Lee-Kong SA, Kiran RP, Stoeckius M, Smibert P, Del Portillo A, Oberstein PE, Sims PA, Yan KS, Han A.
Koido S, Ohkusa T, Homma S, Namiki Y, Takakura K, Saito K, Ito Z, Kobayashi H, Kajihara M, Uchiyama K, Arihiro S, Arakawa H, Okamoto M, Gong J, Tajiri H.
World J Gastroenterol. 2013 Dec 14;19(46):8531-42. doi: 10.3748/wjg.v19.i46.8531.
PMID:24379570
Colorectal cancer: A paradigmatic model for cancer immunology and immunotherapy.
IJsselsteijn ME, Sanz-Pamplona R, Hermitte F, de Miranda NFCC.